Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways

The expression of Triggering Receptor Expressed on Myeloid cells (TREM)-1 has been described as a predictive marker for anti-Tumor Necrosis Factor (TNF)-α monoclonal antibody (mAb) therapy responsiveness in patients with inflammatory bowel disease (IBD). Here we investigated expression of TREM-1 spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Prins, Marileen M., Verstockt, Bram, Ferrante, Marc, Vermeire, Séverine, Wildenberg, Manon E., Koelink, Pim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005579/
https://www.ncbi.nlm.nih.gov/pubmed/33790898
http://dx.doi.org/10.3389/fimmu.2021.627535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005579/
https://www.ncbi.nlm.nih.gov/pubmed/33790898
http://dx.doi.org/10.3389/fimmu.2021.627535

Ejemplares similares